From dashboards to dialogue: why AI is replacing the supply chain control tower

Walk into almost any pharma supply chain operations center and the visual language is instantly familiar: a wall of dashboards, color-coded maps, line charts, heat grids, and an alert ticker down the side. For the better part of a decade, this has been the image of a digitally mature cold chain. Build more sensors, pipe the data into the cloud, surface it on a screen, and the supply chain runs itself.

Except, of course, it doesn’t. Dashboards don’t run supply chains, people do. And there are far more dashboards than there are people.

The data paradox

The move from passive loggers to real-time IoT monitoring was one of the most important shifts in pharma logistics this century. Controlant was a pioneer of that shift, convincing the first pharma company to adopt real-time across its full network in 2018. Five more global pharma companies followed within two years of COVID. Today, leading operators are running at over 99.99% data availability on real-time-enabled lanes, with operational results including massive reductions in product waste from temperature excursions, and in lead times, where temperature-based auto-release has been adopted.

But those gains came with a side effect. More sensors meant more data. More data meant more dashboards. And more dashboards meant that, paradoxically, the more mature the supply chain became, the harder it was for any individual operator to know what to look at.

“I’ve seen more dashboards than I can count. The most common problem isn’t the lack of data, but the lack of an efficient way to cut through the noise.”

— Gísli Herjólfsson, CEO, Controlant, speaking at LogiPharma EU 2026

Data visualization was the right answer to the problem of 2015. It is not the right answer to the problem of 2026.

The question-and-answer supply chain

What is replacing the dashboard is, in a word, dialogue. Supply chain teams are starting to engage with their data the way they already engage with their colleagues: by asking questions.

Natural-language interfaces backed by validated, curated cold chain data let an operator ask ‘which of my lanes have seen the most temperature excursions this quarter, and which carriers are driving them?’ and get a structured answer in under a minute. That is the same answer a three-person analytics team might have produced in three days. For the analyst, it looks like threat; for the supply chain manager, it looks like leverage.

Three things have to be true for this to work. The data has to be qualified end to end, as AI output is only ever as good as the data it’s built on. The cold chain has to be described to the model with enough semantic context that it can reason, not just pattern-match. And the organization has to treat AI output as decision support, not decision authority, so that quality and validation teams can sign off with confidence.

What changes for supply chain leaders

The end of the dashboard era is not the end of data. It is the end of data as the output. In the next phase of pharma cold chain, data is the input, and insight, recommendation, and action are the output.

Practical implications for supply chain leaders:

• Analysts will spend less time building reports and more time validating recommendations.
• Operators will stop scrolling through shipment lists and start triaging prioritized risk briefs.
• Leadership will ask sharper questions, more often, because the cost of asking them has collapsed.

None of that is a reason to rip out the dashboards tomorrow. It is a reason to start treating them as a transitional technology.

Read the whitepaper

From real-time data to real intelligence:
How AI is reshaping the pharmaceutical cold chain

This whitepaper draws on insights shared by Gísli Herjólfsson (CEO at Controlant), and Saddam Huq (Director of Cold Chain & Logistics at GSK) 15 April 2026 at LogiPharma EU, Track B: Delivering Next-Gen AI Supply Chains.